Titan Pharmaceuticals, Inc. (TTNP)

Product Pipeline

Kappa Opioid Receptor Agonist (TP-2021) Implant

for the treatment of moderate-to-severe chronic pruritus

More About Kappa Opioid Receptor Agonist (TP-2021) Implant

Product Pipeline

Nalmefene Implant

for the prevention of relapse in OUD patients following detoxification from opioids

More About Nalmefene Implant

About

Titan Pharmaceuticals

Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura^® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

More About Titan Pharmaceuticals

ProNeura^®

Watch the Mechanism of Action video for the ProNeura technology platform and learn how continuous drug release maintains stable blood levels of medication to help treat chronic diseases.

Watch MOA Video